Overview on Niosome
DOI:
https://doi.org/10.22270/ajprd.v11i4.1295Keywords:
Niosome, Types of niosomes, Method of preparation of niosome, Route of administration,etc.Abstract
Pharmaceutical such achemicals can be administered locally to sick locations using target-specific drug-delivery devices.Some of the carriers used in various drug delivery techniques includesynthetic polymers, serum proteins, and immune globulins, liposomes, and microspheres. Niosomes' vesicular system, which features a bilayer structure made possible by nonionic surfactants, has the capacity to extend the time that a medicine is accessible in a specific region .Capturing hydrophilic molecules in niosomes or lipophilic medicines is enhanced by their amphiphilic character. To keep the niosomes' structure rigid, additional chemicals like cholesterol can be added. The key features of niosomes, such as their structural components, production methods, limitations, and current applications to a range of the narrative review mentions disorders briefly.
Downloads
Download data is not yet available.
References
1. Allen TM. Liposomal drug formulations: rationale for development and what we can expect for the future. Drugs. 1998; 56:747–56.
2. Strebhardt K, Ullrich A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008; 8:473–80.
3. Chen X, Huang W, Wong BC, Yin L, Wong YF, Xu M, et al. Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery. Int J Nanomedicine. 2012; 7:1139–48.
4. Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosome for pulmonary delivery.
5. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011; 1:208–19.
6. Bhaskaran S, Lakshmi PK. Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharma Sci. 2009; 51:27–32.
7. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998; 172:33–70.
8. Negi LM, Garg AK, Chauhan M. Ultra deformable vesicles: concept and execution. Pharma Times. 2009; 41:11–4.
9. Sankar V, Ruckmani K, Jailani S, Ganesan KS, Sharavanan SP. Niosome drug delivery system: advances and medical applications – an overview. Pharmacologyonline. 2009; 2:926–32.
10. Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci. 1995; 58:1–55.
11. Bouwstra JA, van Hal DA, Hofland HEJ, Jun ginger HE. Preparation and characterization of nonionic surfactant vesicles. Colloids Surf A: Physicochemical Eng Aspects. 1997; 123–124:71–80.
12. Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes—non-ionic surfactant vesicles. J Pharm Pharmacology. 1985; 37:863–68.
13. Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, et al. Drug delivery systems: an updated review. Int J Pharma Investing. 2012; 2:2–11. [17] Thacharodi D, R.
14. Bhatt M, Shenoy DS, Udupa N, Srinivas CR. Optimization of delivery of betamethasone-dipropionate from skin preparation. Indian Drugs. 1995; 32:211–4.
15. Diljyot K. Niosomes: a new approach to targeted drug delivery. Int J Pharm Phytopharm Res. 2012; 2:53–9.
16. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994; 31:81–6.
17. Giddi HS, Arunagirinathan MA, Bellare JR. Self-assembled surfactant nano-structures important in drug delivery: a review. Indian J Exp Biol. 2007; 45:133–59.
18. Biju SS, Talegaonkar S, Mishra PR, Khar RK. Vesicular systems: an overview. Indian J Pharm Sci. 2006; 68:141–53.
19. Gandhi A, Sen SO, Paul A. Current trend in niosome as vesicular drug delivery system. Asian J Pharm Life Sci. 2012; 2:339–53.
20. Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee SA, Behera M, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Tech Res. 2010; 1:374–80.
21. Makeshwar K, Wasankar S. Niosomes: a novel drug delivery system. Asian J. Pharm. Res. 2013; 3: 16-20.
22. Sankhyan A, Pawar P. Recent Trends in Niosome as Vesicular Drug Delivery System. Journal of Applied Pharmaceutical Science. 2012; 2: 20-32.
23. Gurjar P. Niosome: A Promising Pharmaceutical Drug Delivery. Int. J. Pharm Anal. 2014; 2: 425-431.
24. Keshavshetti GG, Shirsand SB. Recent advances in niosomal drug delivery - a review. Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences, 2019; 5(3): 514-531.
25. Kalra N, Jeyabalan G. Niosomes: A versatile drug delivery system. Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences, 2016; 2(4): 44-54.
26. Bhat MI, Ganesh NS, Majeed T and Chandy V. Niosomes a controlled and novel drug delivery system: A brief review. World journal of Pharmaceutical sciences, 2019; 3(8): 481-497.
27. Usman MRM, Ghuge PR and Jain BV. Niosomes: a novel trend of drug delivery. European Journal of Biomedical and Pharmaceutical Sciences, 2017; 4(7): 436-442.
28. Sharma D, Ali AAE, aate JR. Niosomes as novel drug delivery system: review article. PharmaTutor, 2018; 6(3): 58-65.
29. Sudheer P, Kaushik K. Review on niosomes – a novel approach for drug targeting. Journal of Pharmaceutical Research, 2015; 14(1): 20-25.
30. Hadjizadeh A, Moghassemi S. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of Controlled Release, 2014; 185: 22–36.
31. Zhang S, Morris ME. Efflux transporters in drug excretion. In: Wang B, Siahaan T, Soltero R, editors. Drug Delivery: Principles and Applications, New Jersey, John Wiley &Sons publishers, 2005 .p. 381–398.
32. Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, et al. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International journal of pharmaceutics. 2018;536(1):95-107.
33. Shtil AA, Grinchuk TM, Tee L, Mechenter EB, and Ignatova TN. Overexpression of P-glycoprotein is associated with a decreased mitochondrial transmembrane potential in doxorubicin selected K562 human leukaemia cells. International Journal of Oncology, 2000; 17: 387–392.
34. Kumar SD, Agarwal S, Sheikh MM, Raveendran S, Rochani AK, Maekawa T. Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy. Royal Society of Chemistry Advances, 2018; 8: 32621- 32636.
35. Amoabediny G, Naderinezhad S, Haghiralsadat F. Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers. Royal Society of Chemistry Advances, 2017; 7: 30008–300019.
36. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T,Kioka N, Komano T and Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. The Journal of Biological Chemistry, 1992; 267(34): 24248- 24252.
37. Greenblatt DJ, Perloff MD, Moltke LLV, Marchand JE. Ritonavir induces P-glycoprotein expression, multidrug resistance associated protein (MRP1) expression, and drug transporter mediated activity in a human intestinal cell line. Journal of Pharmaceutical Sciences, 2001; 90(11): 1829-1837.
38. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharmaceutical Sinica B, 2011; 1(4):208-219.
39. Nasir A, Harikumar SL and Kaur A. Niosomes: An excellent tool for drug delivery. International Journal of Research in Pharmacy and Chemistry’s, 2012; 2(2): 479-487.
40. De S, Girigoswami A, Das S. Fluorescence and dynamic light scattering studies of niosomes membrane mimetic systems. Spectrochimica Acta Part A, 2006; 64: 859-866.
41. Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes-drug entrapment, stability and release. Journal of Microencapsulation, 1987; 4(4): 321– 328.
42. Cummings J, Rogerson A, Florence AT, Willmott N. The distribution of doxorubicin in mice following administration in niosomes. J. Pharm. Pharmacology., 1988; 40: 337-342.
43. Louis D, Mahmoud K, Mohamed M and Ibrahim A. An overview on niosomes: a drug Nano carrier. Drug Designing and Intellectual Properties International Journal, 2018; 1(5): 143- 151.
44. Uchegbu IF, Lalatsa A, Wong D (2013). Polymeric nanoparticles. In: Uchegbu IF, Schatzlein AG, Cheng WP and Lalatsa A editors. Fundamentals of pharmaceutical Nano science, Springer, New York, USA Publishers, .p. 211-234.
45. Khan R, Irchhaiya R. Niosomes: a potential tool for novel drug delivery. Journal of Pharmaceutical Investigation, 2016; 46(3): 195-204.
46. Dwivedi C, Kumar B, Tiwari SP, Satapathy T, Yadav R, Sahu G, Roy A. Niosomes: an excellent tool for drug delivery. Int.J.of Res. in Pharmacology and Pharmacotherapeutics, 2014; 3(3): 192- 204.
47. Cetinel S, Zarrabi A, Durak S, Rad ME, Yetisgin AA, Sutova HE and Kutlu O. Niosomal drug delivery systems for ocular disease—recent advances and future prospects. Nanomaterials, 2020; 10(6): 1-29.
48. More VV, Gilhotra RM, Manoj M. Nitalikar, Prajakta K. Khule. Niosomal drug delivery - a comprehensive review. Asian Journal of Pharmaceutics, 2018; 12(4): 1159-1164.
49. Baillie AJ, Coombs GH, Dolan TF, Laurie J. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J. Pharm Pharmacol., 1986; 38: 502-505.
50. Chavda VP. Niosome: a vesicular weapon for targeted and controlled drug delivery. Indian Journal of Novel Drug Delivery, 2016; 8(3): 133-156.
51. Frank LS and Huang L. Large scale production of DC-Chol cationic liposomes by microfluidization. International Journal of Pharmaceutics, 1996; 144(2): 131–139.
52. Gowda DV, Jain SC, Gupta NV, Kulkarni PK. A brief review on niosomes. Journal of Pharmacy Research, 2017; 11(5): 450-458.
53. Raja NR, Pillai GK, Udupa N, Chandrashekar G. Antiinflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian Journal of Pharmacology, 1994; 26(1): 46-48.
54. Sunilkumar MR, AdlinJinoNesalin J, Man TT. Niosome as a novel drug delivery system-review. Internationa Research Journal of Pharmaceutical and Applied Siences, 2015; 5(3): 1-7.
55. Lohumi A, Rawat S, Sarkar Si, Sipai AB, Yadav MV. A novel drug delivery system: niosomes review. Journal of Drug Delivery & Therapeutics, 2012; 2(5): 129-135.
56. Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochem Biophys Acta, 1985; 816(2): 294- 302.
57. Kuotsu K, Karim MK, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M. Niosome: a future of targeted drug delivery systems. J Adv Pharm Tech Res., 2010; 4(1): 374-380.
58. Navya MN, Parthiban S, Neasalin JAJ, Vikneswari A. Niosomes as novel vesicular drug delivery system- a review. Asian Journal of Research in Biological and Pharmaceutical Sciences, 2014; 2(2): 62-68.
59. Chauhan S, Luorence MJ. The preparation of polyoxyethylene containing non-ionic surfactant vesicles. J Pharm Pharmacol., 1989; 41(6).
60. Yuan WE, Xuemei Ge, Minyan Wei, Suna H. Advances of nonionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics, 2019; 11(2): 1-16.
61. Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Niosomes: a review. Journal of Pharmacy Research, 2011; 4(3): 632-636.
62. Khanam N, Alam MI, Sachan AK, Gangwar SS, Sharma R. Recent trends in drug delivery by niosomes: a review. Asian Journal of Pharmaceutical Research and Development, 2013; 1(3): 115- 122.
63. Sudhamani T, Priyadarisini N, Radhakrishnan M. Proniosomes - a promising drug carriers. International Journal of PharmTech Research, 2010; 2(2): 1446-1454.
64. Almira I, Blazek-Welsh, Rhodes DG. Maltodextrin-Based Proniosomes. AAPS Pharm SciTec., 2001; 3(1): 1-8.
65. Blazek-Walsh AI and Rhodes DG. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharmceutical Research, 2001; 18: 656-661.
66. Gandhi M, Paralkar S, Sonule M, Dabhade D and Pagar S. Niosomes: novel drug delivery system. International Journal of Pure and Applied Bioscience, 2014; 2(2): 267-274.
67. Akhilesh D, Kamath JV. Review on span-60 based non-ionic surfactant vesicles as novel drug delivery. International journal of research in pharmaceutical and biomedical sciences, 2012; 3(1): 6-12.
68. Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374-80. doi: 10.4103/0110-5558.76435, PMID 22247876.
69. Mohamad EA, Aly AA, Khalaf AA, Ahmed MI, Kamel RM, Abdelnaby SM, et al. Evaluation of natural bioactive-derived punicalagin niosomes in skinaging processes accelerated by oxidant and ultraviolet radiation. Drug Des Dev Ther. 2021;15:3151-62. doi: 10.2147/DDDT.S316247, PMID 34321865.
70. Sharma P, Jain AP, Pandey P, Gupta R, Roshan S. Niosome a novel approach for drug delivery system: an overview. Asian Journal of Pharmaceutical science and Research, 2013; 3(5):18- 30.
71. Cummings J, Staurt JF, Calman KC. Determination of adriamycin, adriamycinol and their 7- deoxyaglycones inhuman serum by high performance liquid chromatography. Journal of Chromatography, 1984; 311: 125-33.
72. Vadlamudi CH, Sevukarajan M. Niosomal drug delivery systema review. Indo American Journal of Pharmceutical Research, 2012; 2(9).
73. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics, 1998; 172: 33-70.
74. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. International Journal of Pharmaceutics, 2005; 300: 95-101.
75. Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems - an overview. Advances in Colloid and Interface Science, 2012; 183-184: 46–54.
76. Sarker A, Shimu IJ, Alam SAA. Niosome: as dermal drug delivery tool. IOSR Journal of Pharmacy and Biological Science, 2015; 10(2): 73-79.
77. Sakthivel M, Kannan K, Manavalan, Senthamarai. Non-ionic surfactant vesicles-a review. Research Journal of Pharmaceutical, Biological and Chemical, 2012; 3(1):604-614.
78. Jindal K. Niosomes as a potential carrier system: a review. International Journal of Pharmaceutical, Chemical and Biological Sciences, 2015; 5(4): 947-959.
79. Sternberg B, Uchegbu IF, Florence AT and Murdan S. 1998.
80. Theresa MA. Drugs published by ADIS international Ltd. 1998; 56(5):747-756.
81. Buckton G and Harwood. Interfacial Phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995;154-155.
82. Mujoriya R, Bodla RB, Dhamande K, Singh D and Patle L. Niosomal drug delivery system: the magic bullet. Journal of Applied Pharmaceutical Science, 2011; 1(9): 20-23.
83. Kalra N, Jeyabalan G, Singh G, Choudhary S. Non- ionic surfactant vesicles and their therapeutics potentials. Journal of Innovations in Pharmaceuticals and Biological sciences, 2016; 3 (2): 193-201.
84. Azeem A, Anwer MK and Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. Journal of Drug Targeting, 2009; 17(9): 671-689.
85. Koh RY, Yeo PL, Chye SM and Ling APK. Niosome: a mini review on its structure, properties, methods of preparation and medical applications. Journal of Chemical and Pharmaceutical Research, 2016; 8(10): 231-239.
86. Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Niosomes: a review. Journal of Pharmacy Research, 2011; 4(3): 632-636.
87. Pawar P, Sankhyan A. Recent trends in niosome as vesicular drug delivery system. Journal of Applied Pharmaceutical Science, 2012; 2(6): 20-32.
88. Lalani R, Misra A, Amrutiya J, Patel H, Bhatt P, Patel V. Challenges in Dermal Delivery of Therapeutic Antimicrobial Protein and Peptides. Current Drug Metabolism. 2017; 18(5):426-36.
89. Abd-el-Kader H, Alani AWG and Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Delivery, 2013; 21(2): 87-100.
90. Gayatri Devi S, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int J Pharm Sci 2000;62:479-81
.
2. Strebhardt K, Ullrich A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008; 8:473–80.
3. Chen X, Huang W, Wong BC, Yin L, Wong YF, Xu M, et al. Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery. Int J Nanomedicine. 2012; 7:1139–48.
4. Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosome for pulmonary delivery.
5. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011; 1:208–19.
6. Bhaskaran S, Lakshmi PK. Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharma Sci. 2009; 51:27–32.
7. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998; 172:33–70.
8. Negi LM, Garg AK, Chauhan M. Ultra deformable vesicles: concept and execution. Pharma Times. 2009; 41:11–4.
9. Sankar V, Ruckmani K, Jailani S, Ganesan KS, Sharavanan SP. Niosome drug delivery system: advances and medical applications – an overview. Pharmacologyonline. 2009; 2:926–32.
10. Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci. 1995; 58:1–55.
11. Bouwstra JA, van Hal DA, Hofland HEJ, Jun ginger HE. Preparation and characterization of nonionic surfactant vesicles. Colloids Surf A: Physicochemical Eng Aspects. 1997; 123–124:71–80.
12. Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes—non-ionic surfactant vesicles. J Pharm Pharmacology. 1985; 37:863–68.
13. Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, et al. Drug delivery systems: an updated review. Int J Pharma Investing. 2012; 2:2–11. [17] Thacharodi D, R.
14. Bhatt M, Shenoy DS, Udupa N, Srinivas CR. Optimization of delivery of betamethasone-dipropionate from skin preparation. Indian Drugs. 1995; 32:211–4.
15. Diljyot K. Niosomes: a new approach to targeted drug delivery. Int J Pharm Phytopharm Res. 2012; 2:53–9.
16. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994; 31:81–6.
17. Giddi HS, Arunagirinathan MA, Bellare JR. Self-assembled surfactant nano-structures important in drug delivery: a review. Indian J Exp Biol. 2007; 45:133–59.
18. Biju SS, Talegaonkar S, Mishra PR, Khar RK. Vesicular systems: an overview. Indian J Pharm Sci. 2006; 68:141–53.
19. Gandhi A, Sen SO, Paul A. Current trend in niosome as vesicular drug delivery system. Asian J Pharm Life Sci. 2012; 2:339–53.
20. Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee SA, Behera M, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Tech Res. 2010; 1:374–80.
21. Makeshwar K, Wasankar S. Niosomes: a novel drug delivery system. Asian J. Pharm. Res. 2013; 3: 16-20.
22. Sankhyan A, Pawar P. Recent Trends in Niosome as Vesicular Drug Delivery System. Journal of Applied Pharmaceutical Science. 2012; 2: 20-32.
23. Gurjar P. Niosome: A Promising Pharmaceutical Drug Delivery. Int. J. Pharm Anal. 2014; 2: 425-431.
24. Keshavshetti GG, Shirsand SB. Recent advances in niosomal drug delivery - a review. Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences, 2019; 5(3): 514-531.
25. Kalra N, Jeyabalan G. Niosomes: A versatile drug delivery system. Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences, 2016; 2(4): 44-54.
26. Bhat MI, Ganesh NS, Majeed T and Chandy V. Niosomes a controlled and novel drug delivery system: A brief review. World journal of Pharmaceutical sciences, 2019; 3(8): 481-497.
27. Usman MRM, Ghuge PR and Jain BV. Niosomes: a novel trend of drug delivery. European Journal of Biomedical and Pharmaceutical Sciences, 2017; 4(7): 436-442.
28. Sharma D, Ali AAE, aate JR. Niosomes as novel drug delivery system: review article. PharmaTutor, 2018; 6(3): 58-65.
29. Sudheer P, Kaushik K. Review on niosomes – a novel approach for drug targeting. Journal of Pharmaceutical Research, 2015; 14(1): 20-25.
30. Hadjizadeh A, Moghassemi S. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of Controlled Release, 2014; 185: 22–36.
31. Zhang S, Morris ME. Efflux transporters in drug excretion. In: Wang B, Siahaan T, Soltero R, editors. Drug Delivery: Principles and Applications, New Jersey, John Wiley &Sons publishers, 2005 .p. 381–398.
32. Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, et al. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International journal of pharmaceutics. 2018;536(1):95-107.
33. Shtil AA, Grinchuk TM, Tee L, Mechenter EB, and Ignatova TN. Overexpression of P-glycoprotein is associated with a decreased mitochondrial transmembrane potential in doxorubicin selected K562 human leukaemia cells. International Journal of Oncology, 2000; 17: 387–392.
34. Kumar SD, Agarwal S, Sheikh MM, Raveendran S, Rochani AK, Maekawa T. Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy. Royal Society of Chemistry Advances, 2018; 8: 32621- 32636.
35. Amoabediny G, Naderinezhad S, Haghiralsadat F. Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers. Royal Society of Chemistry Advances, 2017; 7: 30008–300019.
36. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T,Kioka N, Komano T and Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. The Journal of Biological Chemistry, 1992; 267(34): 24248- 24252.
37. Greenblatt DJ, Perloff MD, Moltke LLV, Marchand JE. Ritonavir induces P-glycoprotein expression, multidrug resistance associated protein (MRP1) expression, and drug transporter mediated activity in a human intestinal cell line. Journal of Pharmaceutical Sciences, 2001; 90(11): 1829-1837.
38. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharmaceutical Sinica B, 2011; 1(4):208-219.
39. Nasir A, Harikumar SL and Kaur A. Niosomes: An excellent tool for drug delivery. International Journal of Research in Pharmacy and Chemistry’s, 2012; 2(2): 479-487.
40. De S, Girigoswami A, Das S. Fluorescence and dynamic light scattering studies of niosomes membrane mimetic systems. Spectrochimica Acta Part A, 2006; 64: 859-866.
41. Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes-drug entrapment, stability and release. Journal of Microencapsulation, 1987; 4(4): 321– 328.
42. Cummings J, Rogerson A, Florence AT, Willmott N. The distribution of doxorubicin in mice following administration in niosomes. J. Pharm. Pharmacology., 1988; 40: 337-342.
43. Louis D, Mahmoud K, Mohamed M and Ibrahim A. An overview on niosomes: a drug Nano carrier. Drug Designing and Intellectual Properties International Journal, 2018; 1(5): 143- 151.
44. Uchegbu IF, Lalatsa A, Wong D (2013). Polymeric nanoparticles. In: Uchegbu IF, Schatzlein AG, Cheng WP and Lalatsa A editors. Fundamentals of pharmaceutical Nano science, Springer, New York, USA Publishers, .p. 211-234.
45. Khan R, Irchhaiya R. Niosomes: a potential tool for novel drug delivery. Journal of Pharmaceutical Investigation, 2016; 46(3): 195-204.
46. Dwivedi C, Kumar B, Tiwari SP, Satapathy T, Yadav R, Sahu G, Roy A. Niosomes: an excellent tool for drug delivery. Int.J.of Res. in Pharmacology and Pharmacotherapeutics, 2014; 3(3): 192- 204.
47. Cetinel S, Zarrabi A, Durak S, Rad ME, Yetisgin AA, Sutova HE and Kutlu O. Niosomal drug delivery systems for ocular disease—recent advances and future prospects. Nanomaterials, 2020; 10(6): 1-29.
48. More VV, Gilhotra RM, Manoj M. Nitalikar, Prajakta K. Khule. Niosomal drug delivery - a comprehensive review. Asian Journal of Pharmaceutics, 2018; 12(4): 1159-1164.
49. Baillie AJ, Coombs GH, Dolan TF, Laurie J. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J. Pharm Pharmacol., 1986; 38: 502-505.
50. Chavda VP. Niosome: a vesicular weapon for targeted and controlled drug delivery. Indian Journal of Novel Drug Delivery, 2016; 8(3): 133-156.
51. Frank LS and Huang L. Large scale production of DC-Chol cationic liposomes by microfluidization. International Journal of Pharmaceutics, 1996; 144(2): 131–139.
52. Gowda DV, Jain SC, Gupta NV, Kulkarni PK. A brief review on niosomes. Journal of Pharmacy Research, 2017; 11(5): 450-458.
53. Raja NR, Pillai GK, Udupa N, Chandrashekar G. Antiinflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian Journal of Pharmacology, 1994; 26(1): 46-48.
54. Sunilkumar MR, AdlinJinoNesalin J, Man TT. Niosome as a novel drug delivery system-review. Internationa Research Journal of Pharmaceutical and Applied Siences, 2015; 5(3): 1-7.
55. Lohumi A, Rawat S, Sarkar Si, Sipai AB, Yadav MV. A novel drug delivery system: niosomes review. Journal of Drug Delivery & Therapeutics, 2012; 2(5): 129-135.
56. Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochem Biophys Acta, 1985; 816(2): 294- 302.
57. Kuotsu K, Karim MK, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M. Niosome: a future of targeted drug delivery systems. J Adv Pharm Tech Res., 2010; 4(1): 374-380.
58. Navya MN, Parthiban S, Neasalin JAJ, Vikneswari A. Niosomes as novel vesicular drug delivery system- a review. Asian Journal of Research in Biological and Pharmaceutical Sciences, 2014; 2(2): 62-68.
59. Chauhan S, Luorence MJ. The preparation of polyoxyethylene containing non-ionic surfactant vesicles. J Pharm Pharmacol., 1989; 41(6).
60. Yuan WE, Xuemei Ge, Minyan Wei, Suna H. Advances of nonionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics, 2019; 11(2): 1-16.
61. Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Niosomes: a review. Journal of Pharmacy Research, 2011; 4(3): 632-636.
62. Khanam N, Alam MI, Sachan AK, Gangwar SS, Sharma R. Recent trends in drug delivery by niosomes: a review. Asian Journal of Pharmaceutical Research and Development, 2013; 1(3): 115- 122.
63. Sudhamani T, Priyadarisini N, Radhakrishnan M. Proniosomes - a promising drug carriers. International Journal of PharmTech Research, 2010; 2(2): 1446-1454.
64. Almira I, Blazek-Welsh, Rhodes DG. Maltodextrin-Based Proniosomes. AAPS Pharm SciTec., 2001; 3(1): 1-8.
65. Blazek-Walsh AI and Rhodes DG. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharmceutical Research, 2001; 18: 656-661.
66. Gandhi M, Paralkar S, Sonule M, Dabhade D and Pagar S. Niosomes: novel drug delivery system. International Journal of Pure and Applied Bioscience, 2014; 2(2): 267-274.
67. Akhilesh D, Kamath JV. Review on span-60 based non-ionic surfactant vesicles as novel drug delivery. International journal of research in pharmaceutical and biomedical sciences, 2012; 3(1): 6-12.
68. Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374-80. doi: 10.4103/0110-5558.76435, PMID 22247876.
69. Mohamad EA, Aly AA, Khalaf AA, Ahmed MI, Kamel RM, Abdelnaby SM, et al. Evaluation of natural bioactive-derived punicalagin niosomes in skinaging processes accelerated by oxidant and ultraviolet radiation. Drug Des Dev Ther. 2021;15:3151-62. doi: 10.2147/DDDT.S316247, PMID 34321865.
70. Sharma P, Jain AP, Pandey P, Gupta R, Roshan S. Niosome a novel approach for drug delivery system: an overview. Asian Journal of Pharmaceutical science and Research, 2013; 3(5):18- 30.
71. Cummings J, Staurt JF, Calman KC. Determination of adriamycin, adriamycinol and their 7- deoxyaglycones inhuman serum by high performance liquid chromatography. Journal of Chromatography, 1984; 311: 125-33.
72. Vadlamudi CH, Sevukarajan M. Niosomal drug delivery systema review. Indo American Journal of Pharmceutical Research, 2012; 2(9).
73. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics, 1998; 172: 33-70.
74. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. International Journal of Pharmaceutics, 2005; 300: 95-101.
75. Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems - an overview. Advances in Colloid and Interface Science, 2012; 183-184: 46–54.
76. Sarker A, Shimu IJ, Alam SAA. Niosome: as dermal drug delivery tool. IOSR Journal of Pharmacy and Biological Science, 2015; 10(2): 73-79.
77. Sakthivel M, Kannan K, Manavalan, Senthamarai. Non-ionic surfactant vesicles-a review. Research Journal of Pharmaceutical, Biological and Chemical, 2012; 3(1):604-614.
78. Jindal K. Niosomes as a potential carrier system: a review. International Journal of Pharmaceutical, Chemical and Biological Sciences, 2015; 5(4): 947-959.
79. Sternberg B, Uchegbu IF, Florence AT and Murdan S. 1998.
80. Theresa MA. Drugs published by ADIS international Ltd. 1998; 56(5):747-756.
81. Buckton G and Harwood. Interfacial Phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995;154-155.
82. Mujoriya R, Bodla RB, Dhamande K, Singh D and Patle L. Niosomal drug delivery system: the magic bullet. Journal of Applied Pharmaceutical Science, 2011; 1(9): 20-23.
83. Kalra N, Jeyabalan G, Singh G, Choudhary S. Non- ionic surfactant vesicles and their therapeutics potentials. Journal of Innovations in Pharmaceuticals and Biological sciences, 2016; 3 (2): 193-201.
84. Azeem A, Anwer MK and Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. Journal of Drug Targeting, 2009; 17(9): 671-689.
85. Koh RY, Yeo PL, Chye SM and Ling APK. Niosome: a mini review on its structure, properties, methods of preparation and medical applications. Journal of Chemical and Pharmaceutical Research, 2016; 8(10): 231-239.
86. Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Niosomes: a review. Journal of Pharmacy Research, 2011; 4(3): 632-636.
87. Pawar P, Sankhyan A. Recent trends in niosome as vesicular drug delivery system. Journal of Applied Pharmaceutical Science, 2012; 2(6): 20-32.
88. Lalani R, Misra A, Amrutiya J, Patel H, Bhatt P, Patel V. Challenges in Dermal Delivery of Therapeutic Antimicrobial Protein and Peptides. Current Drug Metabolism. 2017; 18(5):426-36.
89. Abd-el-Kader H, Alani AWG and Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Delivery, 2013; 21(2): 87-100.
90. Gayatri Devi S, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int J Pharm Sci 2000;62:479-81
.
Published
2023-08-13
How to Cite
Sanket, K., Prakash, J., & Vivekkumar, R. (2023). Overview on Niosome. Asian Journal of Pharmaceutical Research and Development, 11(4), 143–154. https://doi.org/10.22270/ajprd.v11i4.1295
Issue
Section
Review Articles
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.